Related Experiment Video
Updated: Jun 1, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Elevated Inflammation and Adhesion Molecule hsCRP, GDF-15 and VCAM-1 in Angina Patients with Non-obstructive Coronary
Zulkefli Sanip1, Aida Hanum Ghulam Rasool2, Nurnajwa Pahimi2,3
1Central Research Laboratory, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Insights
Biomarkers like VCAM-1 are elevated in non-obstructive coronary artery disease (NOCAD) and can predict its occurrence. Peripheral levels of hsCRP, GDF-15, and VCAM-1 correlate with coronary levels, suggesting their potential as early NOCAD indicators.
Area of Science:
- Cardiology
- Biomarker Research
- Inflammation and Immunology
Background:
- Non-obstructive coronary artery disease (NOCAD) presents with angina but without significant blockages.
- Understanding biomarkers in NOCAD is crucial for diagnosis and management.
- This study investigates inflammation and adhesion molecules in NOCAD.
Purpose of the Study:
- To evaluate the roles of inflammation and adhesion molecules in NOCAD development.
- To explore correlations between peripheral and coronary levels of these biomarkers.
- To identify potential early biomarkers for NOCAD.
Main Methods:
- Cross-sectional study of symptomatic angina patients undergoing coronary angiography.
- Categorization into obstructive coronary artery disease (OCAD) and NOCAD groups.
- Measurement of high sensitivity C-reactive protein (hsCRP), growth differentiation factor 15 (GDF-15), and vascular cell adhesion molecule-1 (VCAM-1) in peripheral and coronary blood.
Main Results:
- Elevated hsCRP, GDF-15, and VCAM-1 levels were observed in both OCAD and NOCAD groups compared to controls.
- VCAM-1 levels significantly predicted NOCAD incidence (AUC = 0.716).
- Strong correlations were found between peripheral and coronary levels of all measured biomarkers in both OCAD and NOCAD patients.
Conclusions:
- NOCAD is associated with elevated hsCRP, GDF-15, and VCAM-1, even without obstructive lesions.
- VCAM-1 shows promise as an early predictive biomarker for NOCAD.
- Peripheral biomarker levels reflect coronary levels, offering potential for non-invasive assessment.
Background:
Non-obstructive coronary artery disease (NOCAD) is a condition in stable patients that experience angina despite not having significant coronary obstructive lesion. Knowledge on the role of certain biomarkers in patients with NOCAD is still limited. This study aimed to evaluate the roles of inflammation and adhesion molecules in the development of NOCAD. The correlations between the peripheral and coronary levels of the inflammatory biomarkers and adhesion molecules were also investigated.
Methods:
In this cross-sectional study, symptomatic angina patients scheduled for coronary angiograms were recruited and separated into obstructive coronary artery disease (OCAD) and NOCAD groups based on those angiograms. Peripheral and coronary blood samples were taken to measure inflammation biomarkers [high sensitivity C-reactive protein (hsCRP) and growth differentiation factor 15 (GDF-15)], and adhesion molecules [vascular cell adhesion molecule-1 (VCAM-1)]. Subjects without angina symptoms were recruited for the control group.
Results:
The hsCRP, GDF-15, and VCAM-1 levels were higher in the OCAD and NOCAD groups than in the control group. VCAM-1 levels successfully predicted the incidence of NOCAD [p = 0.010, area under the curve (AUC) = 0.716]. All biomarkers' levels in the peripheral and coronary blood were correlated in OCAD and NOCAD patients (p < 0.001).
Conclusion:
Elevated levels of the hsCRP, GDF-15, and VCAM-1 were found with NOCAD, despite the absent of significant coronary obstruction. VCAM-1 successfully predicted NOCAD and may thus serve as an early NOCAD biomarker. Significant correlations of hsCRP, GDF-15, and VCAM-1 level in peripheral and coronary blood indicate that the peripheral levels of these biomarkers reflect the levels and changes that occur at the coronary level.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Adherens Junctions
Adherens Junctions are Dynamic
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Regulation of Angiogenesis and Blood Supply

